Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3f14575d0ba7180a1371b14fff340d5 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate |
2010-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3396d5e6f8358d4cec34114cf5f31e30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77c7665289b5f9de683c9e599a22b2c4 |
publicationDate |
2010-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2010222347-A |
titleOfInvention |
Pharmaceutical composition containing PDE5 inhibitor and carnitine |
abstract |
【Task】 To provide a pharmaceutical composition that is safe and has enhanced erection action. [Solution] A pharmaceutical composition comprising a phosphodiesterase 5 inhibitor; and an L-carnitine acid adduct. [Selection figure] None |
priorityDate |
2009-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |